14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 ALDX stock ended at $4.07. This is 2.40% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 2.97% from a day low at $4.05 to a day high of $4.17.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Jul 05, 2016 $6.14 $6.14 $6.14 $6.14 20 400
Jul 01, 2016 $6.05 $6.05 $6.05 $6.05 95 300
Jun 30, 2016 $5.69 $5.69 $5.69 $5.69 51 300
Jun 29, 2016 $5.50 $5.50 $5.50 $5.50 29 800
Jun 28, 2016 $5.39 $5.39 $5.39 $5.39 28 200
Jun 27, 2016 $5.24 $5.24 $5.24 $5.24 95 000
Jun 24, 2016 $5.30 $5.30 $5.30 $5.30 15 400
Jun 23, 2016 $5.14 $5.14 $5.14 $5.14 37 100
Jun 22, 2016 $5.18 $5.18 $5.18 $5.18 21 200
Jun 21, 2016 $5.02 $5.02 $5.02 $5.02 19 600
Jun 20, 2016 $5.25 $5.25 $5.25 $5.25 74 700
Jun 17, 2016 $5.35 $5.35 $5.35 $5.35 22 900
Jun 16, 2016 $5.25 $5.25 $5.25 $5.25 19 249
Jun 15, 2016 $5.50 $5.50 $5.50 $5.50 4 771
Jun 14, 2016 $5.27 $5.27 $5.27 $5.27 28 251
Jun 13, 2016 $5.76 $5.76 $5.76 $5.76 11 349
Jun 10, 2016 $5.84 $5.84 $5.84 $5.84 33 343
Jun 09, 2016 $5.97 $5.97 $5.97 $5.97 14 577
Jun 08, 2016 $5.73 $5.73 $5.73 $5.73 30 208
Jun 07, 2016 $5.93 $5.93 $5.93 $5.93 67 862
Jun 06, 2016 $5.60 $5.60 $5.60 $5.60 48 974
Jun 03, 2016 $5.62 $5.62 $5.62 $5.62 61 816
Jun 02, 2016 $5.85 $5.85 $5.85 $5.85 41 999
Jun 01, 2016 $5.95 $5.95 $5.95 $5.95 84 379
May 31, 2016 $5.81 $5.81 $5.81 $5.81 74 486
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT